CytoDyn Inc. (OTCMKTS: CYDY) Releases Leronlimab Results of COVID-19 Long-Haulers Study
CytoDyn Inc. (OTCMKTS: CYDY) has announced the initial result following the unblinding of the data from the ongoing long COVID clinical trial. Leronlimba alleviated COVID-19 symptoms. The COVID-19 long-haulers study sought to assess the efficacy and safety of leronlimab delivered subcutaneously weekly to subjects showing prolonged COVID-19 symptoms. The study’s primary endpoint was a change from baseline in COVID-19 related symptom severity through the 56th day. Progression of COVID-19-related symptoms…